They observed the beneficial effects of both cell types in attenuating CKD progression, which was indicated by improvement of clinical and histological CKD parameters, including decreased tubulointerstitial damage (interstitial fibrosis and tubular atrophy), glomerulosclerosis and α-SMA. Here, ACTA1 is linked to chronic kidney disease.